Discovery of AX8312, an N-alkyl-Gly-boro-Pro Derivative that Accelerates Recovery from Neutropenia in the Mouse

Author(s): Emme C.K. Lin, Kevin R. Shreder, Melissa C. Zhang, Yi Hu, Lisa Morera, Min Wu, Melissa S. Wong, Lifu Ma, Doris Chun, Sergio Corral, John W. Kozarich

Journal Name: Letters in Drug Design & Discovery

Volume 5 , Issue 5 , 2008

Become EABM
Become Reviewer
Call for Editor


A screen of N-alkyl-Gly-boro-Pro DPP inhibitors using an acute murine model revealed that N-adamantyl and N-cycloalkyl groups greater in size than cyclobutyl significantly induced G-CSF. Treatment of neutropenic mice with the most efficacious compound, AX8312 (N-(1-adamantyl)-Gly-boro-Pro), resulted in a faster and greater neutrophil recovery versus vehicle-treated mice.

Keywords: N-alkyl-Gly-boro-Pro, G-CSF, Neutropenia, Cytokine, AX8312

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [340 - 345]
Pages: 6
DOI: 10.2174/157018008784912081
Price: $65

Article Metrics

PDF: 3